180 related articles for article (PubMed ID: 25243851)
1. Investigation of 6-[¹⁸F]-fluoromaltose as a novel PET tracer for imaging bacterial infection.
Gowrishankar G; Namavari M; Jouannot EB; Hoehne A; Reeves R; Hardy J; Gambhir SS
PLoS One; 2014; 9(9):e107951. PubMed ID: 25243851
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of [¹⁸F]-labelled maltose derivatives as PET tracers for imaging bacterial infection.
Namavari M; Gowrishankar G; Hoehne A; Jouannot E; Gambhir SS
Mol Imaging Biol; 2015 Apr; 17(2):168-76. PubMed ID: 25277604
[TBL] [Abstract][Full Text] [Related]
3. Specific Imaging of Bacterial Infection Using 6″-
Gowrishankar G; Hardy J; Wardak M; Namavari M; Reeves RE; Neofytou E; Srinivasan A; Wu JC; Contag CH; Gambhir SS
J Nucl Med; 2017 Oct; 58(10):1679-1684. PubMed ID: 28490473
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
Ohshima Y; Hanaoka H; Tominaga H; Kanai Y; Kaira K; Yamaguchi A; Nagamori S; Oriuchi N; Tsushima Y; Endo K; Ishioka NS
Ann Nucl Med; 2013 May; 27(4):314-24. PubMed ID: 23337966
[TBL] [Abstract][Full Text] [Related]
5. A novel synthesis of 6''-[
Namavari M; Gowrishankar G; Srinivasan A; Gambhir SS; Haywood T; Beinat C
J Labelled Comp Radiopharm; 2018 May; 61(5):408-414. PubMed ID: 29314161
[TBL] [Abstract][Full Text] [Related]
6. [
Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
[TBL] [Abstract][Full Text] [Related]
7. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.
Langer O; Brunner M; Zeitlinger M; Ziegler S; Müller U; Dobrozemsky G; Lackner E; Joukhadar C; Mitterhauser M; Wadsak W; Minar E; Dudczak R; Kletter K; Müller M
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):143-50. PubMed ID: 15690222
[TBL] [Abstract][Full Text] [Related]
9. New synthesis of 6″-[
Gabr MT; Haywood T; Gowrishankar G; Srinivasan A; Gambhir SS
J Labelled Comp Radiopharm; 2020 Sep; 63(11):466-475. PubMed ID: 32602175
[TBL] [Abstract][Full Text] [Related]
10. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
[TBL] [Abstract][Full Text] [Related]
11. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.
Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J
Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080
[No Abstract] [Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging of
Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
[TBL] [Abstract][Full Text] [Related]
15. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients.
Dumarey N; Egrise D; Blocklet D; Stallenberg B; Remmelink M; del Marmol V; Van Simaeys G; Jacobs F; Goldman S
J Nucl Med; 2006 Apr; 47(4):625-32. PubMed ID: 16595496
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Approach for Developing Bacteria-Specific Imaging Tracers.
Ordonez AA; Weinstein EA; Bambarger LE; Saini V; Chang YS; DeMarco VP; Klunk MH; Urbanowski ME; Moulton KL; Murawski AM; Pokkali S; Kalinda AS; Jain SK
J Nucl Med; 2017 Jan; 58(1):144-150. PubMed ID: 27635025
[TBL] [Abstract][Full Text] [Related]
17. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
19. Imaging of a localized bacterial infection with endogenous thymidine kinase using radioisotope-labeled nucleosides.
Jang SJ; Lee YJ; Lim S; Kim KI; Lee KC; An GI; Lee TS; Cheon GJ; Lim SM; Kang JH
Int J Med Microbiol; 2012 Mar; 302(2):101-7. PubMed ID: 22264560
[TBL] [Abstract][Full Text] [Related]
20. Development of [
Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
